LncRNA GAS5 rs145204276 Polymorphism Reduces Renal Cell Carcinoma Susceptibility in Southern Chinese Population

References

• Kapoor A. Kidney cancer, ESMO 2016. Can Urol Assoc J. 2016;10(11–12Suppl6):S227–S230. doi:10.5489/cuaj.4282
   PubMed Web of Science ®Google Scholar
• Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009. doi:10.1038/nrdp.2017.9
   PubMed Web of Science ®Google Scholar
• Semenza JC, Ziogas A, Largent J, Peel D, Anton-Culver H. Gene-environment interactions in renal cell carcinoma. Am J Epidemiol. 2001;153(9):851–859. doi:10.1093/aje/153.9.851
   PubMed Web of Science ®Google Scholar
• Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7(5):245–257. doi:10.1038/nrurol.2010.46
   PubMed Web of Science ®Google Scholar
• Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, Medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer. 2004;108(1):115–121. doi:10.1002/ijc.11532
   PubMed Web of Science ®Google Scholar
• Gudmundsson J, Sulem P, Gudbjartsson DF, et al. A common variant at 8q24.21 is associated with renal cell cancer. Nat Commun. 2013;4:2776. doi:10.1038/ncomms3776
   PubMed Web of Science ®Google Scholar
• Purdue MP, Johansson M, Zelenika D, et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet. 2011;43(1):60–65. doi:10.1038/ng.723
   PubMed Web of Science ®Google Scholar
• Schodel J, Bardella C, Sciesielski LK, et al. Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression. Nat Genet. 2012;44(4):420–425, S421-422. doi:10.1038/ng.2204
   PubMed Web of Science ®Google Scholar
• Wu X, Scelo G, Purdue MP, et al. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet. 2012;21(2):456–462. doi:10.1093/hmg/ddr479
   PubMed Web of Science ®Google Scholar
• Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20(3):300–307. doi:10.1038/nsmb.2480
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou J. LncRNAs: macromolecules with big roles in neurobiology and neurological Diseases. Metab Brain Dis. 2017;32(2):281–291. doi:10.1007/s11011-017-9965-8
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339(2):159–166. doi:10.1016/j.canlet.2013.06.013
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang R, Lian J, Xu H. LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer. Am J Transl Res. 2016;8(11):5035–5043.
   PubMed Web of Science ®Google Scholar
• Xu E, Yu X, Zeng Q, et al. Functional role of lncRNA DB327252 in lung cancer. J Thorac Dis. 2016;8(10):2793–2802. doi:10.21037/jtd.2016.10.44
   PubMed Web of Science ®Google Scholar
• Xia H, Chen Q, Chen Y, et al. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis. Oncotarget. 2016;7(35):56209–56218. doi:10.18632/oncotarget.10941
   PubMedGoogle Scholar
• Taheri M, Omrani MD, Ghafouri-Fard S. Long non-coding RNAs expression in renal cell carcinoma. J Biol Today’s World. 2017;6(12):240–247.
   Google Scholar
• Zhang H, Guo Y, Song Y, Shang C. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma. Cancer Chemother Pharmacol. 2017;79(1):49–55. doi:10.1007/s00280-016-3194-4
   PubMed Web of Science ®Google Scholar
• Mahdi Eftekharian M, Noroozi R, Komaki A, Mazdeh M, Taheri M, Ghafouri-Fard S. GAS5 genomic variants and risk of multiple sclerosis. Neurosci Lett. 2019;701:54–57. doi:10.1016/j.neulet.2019.02.028
   PubMed Web of Science ®Google Scholar
• Ye K, Wang S, Zhang H, Han H, Ma B, Nan W. Long noncoding RNA GAS5 suppresses cell growth and epithelial-mesenchymal transition in osteosarcoma by regulating the miR-221/ARHI pathway. J Cell Biochem. 2017;118(12):4772–4781. doi:10.1002/jcb.26145
   PubMed Web of Science ®Google Scholar
• Zheng Y, Song D, Xiao K, et al. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer. Oncotarget. 2016;7(50):83727–83734. doi:10.18632/oncotarget.13384
   PubMedGoogle Scholar
• Li W, Zhai L, Wang H, et al. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer. Oncotarget. 2016;7(19):27778–27786. doi:10.18632/oncotarget.8413
   PubMedGoogle Scholar
• Liu Z, Wang W, Jiang J, et al. Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6. PLoS One. 2013;8(9):e73991. doi:10.1371/journal.pone.0073991
   PubMed Web of Science ®Google Scholar
• Ghaforui-Fard S, Taheri M. Growth arrest specific transcript 5 in tumorigenesis process: an update on the expression pattern and genomic variants. Biomed Pharmacother. 2019;112:108723. doi:10.1016/j.biopha.2019.108723
   PubMed Web of Science ®Google Scholar
• Qiao HP, Gao WS, Huo JX, Yang ZS. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prev. 2013;14(2):1077–1082. doi:10.7314/APJCP.2013.14.2.1077
   PubMedGoogle Scholar
• Liu L, Pang X, Shang W, Xie H, Feng Y, Feng G. Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21/SOX5 pathway. Cell Cycle. 2019;18(3):257–263. doi:10.1080/15384101.2018.1475826
   PubMed Web of Science ®Google Scholar
• Zhou S, Wang J, Zhang Z. An emerging understanding of long noncoding RNAs in kidney cancer. J Cancer Res Clin Oncol. 2014;140(12):1989–1995. doi:10.1007/s00432-014-1699-y
   PubMed Web of Science ®Google Scholar
• Toraih EA, Alghamdi SA, El-Wazir A, et al. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors. PLoS One. 2018;13(10):e0198231. doi:10.1371/journal.pone.0198231
   PubMed Web of Science ®Google Scholar
• Li Q, Ma G, Sun S, Xu Y, Wang B. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer. Clin Res Hepatol Gastroenterol. 2018;42(5):478–482. doi:10.1016/j.clinre.2018.01.006
   PubMed Web of Science ®Google Scholar
• Tao R, Hu S, Wang S, et al. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. Carcinogenesis. 2015;36(10):1136–1143. doi:10.1093/carcin/bgv099
   PubMed Web of Science ®Google Scholar
• Yu J, Ding C, Guan S, Wang C. Association of single nucleotide polymorphisms in the RAB5B gene 3ʹUTR region with polycystic ovary syndrome in Chinese Han women. Biosci Rep. 2019;39:5. doi:10.1042/BSR20190292
   Web of Science ®Google Scholar
• Rakhshan A, Esmaeili MH, Kahaei MS, et al. A single nucleotide polymorphism in GAS5 lncRNA is associated with risk of bladder cancer in Iranian Population. Pathol Oncol Res. 2019;26(2):1251–1254. doi:10.1007/s12253-019-00693-2
   PubMed Web of Science ®Google Scholar
• Kim SP, Alt AL, Weight CJ, et al. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. J Urol. 2011;185(6):2035–2039. doi:10.1016/j.juro.2011.02.059
   PubMed Web of Science ®Google Scholar
• Bezhanova SD. [Tumors of the kidney. The new 2016 WHO classification of tumors of the genitourinary system]. Arkh Patol. 2017;79(2):48–52. Russian. doi:10.17116/patol201779248-52
   PubMedGoogle Scholar
• Delahunt B, Egevad L, Samaratunga H, Martignoni G, Nacey JN, Srigley JR. Gleason and Fuhrman no longer make the grade. Histopathology. 2016;68(4):475–481. doi:10.1111/his.12803
   PubMed Web of Science ®Google Scholar
• Zhu L, Zhu Q, Wen H, Huang X, Zheng G. Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5. J Cell Physiol. 2019;234(6):8928–8940. doi:10.1002/jcp.27561
   PubMed Web of Science ®Google Scholar
• Moradi M, Gharesouran J, Ghafouri-Fard S, et al. Role of NR3C1 and GAS5 genes polymorphisms in multiple sclerosis. Int J Neurosci. 2020;130(4):407–412. doi:10.1080/00207454.2019.1694019
   PubMed Web of Science ®Google Scholar
• Chen L, Hu W, Li S, et al. Genetic variants of ADAMTS7 confer risk for ischaemic stroke in the Chinese population. Aging (Albany NY). 2019;11(16):6569–6583. doi:10.18632/aging.102211
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog. 2015;54(Suppl 1):E1–E12. doi:10.1002/mc.22120
   PubMed Web of Science ®Google Scholar
• Liu L, Meng T, Yang XH, et al. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion. Cancer Biomark. 2018;22(2):283–299. doi:10.3233/CBM-171011
   PubMed Web of Science ®Google Scholar
• Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28(2):195–208. doi:10.1038/onc.2008.373
   PubMed Web of Science ®Google Scholar
• Sun M, Jin FY, Xia R, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014;14:319. doi:10.1186/1471-2407-14-319
   PubMed Web of Science ®Google Scholar
• Pickard MR, Mourtada-Maarabouni M, Williams GT. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta. 2013;1832(10):1613–1623. doi:10.1016/j.bbadis.2013.05.005
   PubMed Web of Science ®Google Scholar
• Lu X, Fang Y, Wang Z, et al. Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6. Cell Tissue Res. 2013;354(3):891–896. doi:10.1007/s00441-013-1711-x
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu S, Yang X, Li X, Chen R. Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer. Biosci Rep. 2019;39:4.
   Web of Science ®Google Scholar
• Capitanio U, Bensalah K, Bex A, et al. Epidemiology of Renal Cell Carcinoma. Eur Urol. 2019;75(1):74–84. doi:10.1016/j.eururo.2018.08.036
   PubMed Web of Science ®Google Scholar
• Macleod LC, Hotaling JM, Wright JL, et al. Risk factors for renal cell carcinoma in the VITAL study. J Urol. 2013;190(5):1657–1661. doi:10.1016/j.juro.2013.04.130
   PubMed Web of Science ®Google Scholar
• Lotan Y, Karam JA, Shariat SF, et al. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. Urol Oncol. 2016;34(4):167 e169–116. doi:10.1016/j.urolonc.2015.10.011
   Web of Science ®Google Scholar
• Germano G, Allavena P, Mantovani A. Cytokines as a key component of cancer-related inflammation. Cytokine. 2008;43(3):374–379. doi:10.1016/j.cyto.2008.07.014
   PubMed Web of Science ®Google Scholar
• Xu L, Xia C, Xue B, Sheng F, Xiong J, Wang S. A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma. J Bone Oncol. 2018;12:23–26. doi:10.1016/j.jbo.2018.03.001
   PubMed Web of Science ®Google Scholar
• Tang Y, Wang Y, Wang X, Liu Y, Zheng K, Genetic A. Variant of rs145204276 in the promoter region of long noncoding RNA GAS5 is associated with a reduced risk of breast cancer. Clin Breast Cancer. 2019;19(3):e415–e421. doi:10.1016/j.clbc.2018.11.006
   PubMed Web of Science ®Google Scholar
• Yuan J, Zhang N, Zheng Y, Chen YD, Liu J, Yang M. LncRNA GAS5 indel genetic polymorphism contributes to glioma risk through interfering binding of transcriptional factor TFAP2A. DNA Cell Biol. 2018;37(9):750–757. doi:10.1089/dna.2018.4215
   PubMed Web of Science ®Google Scholar
• Yan H, Zhang DY, Li X, et al. Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution. Leuk Lymphoma. 2017;58(8):1948–1957. doi:10.1080/10428194.2016.1266626
   PubMed Web of Science ®Google Scholar